KR20020086905A - 노르에티스테론을 포함하는 남성 피임약 제형 - Google Patents

노르에티스테론을 포함하는 남성 피임약 제형 Download PDF

Info

Publication number
KR20020086905A
KR20020086905A KR1020027010715A KR20027010715A KR20020086905A KR 20020086905 A KR20020086905 A KR 20020086905A KR 1020027010715 A KR1020027010715 A KR 1020027010715A KR 20027010715 A KR20027010715 A KR 20027010715A KR 20020086905 A KR20020086905 A KR 20020086905A
Authority
KR
South Korea
Prior art keywords
formulation
net
testosterone
androgen
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020027010715A
Other languages
English (en)
Korean (ko)
Inventor
니에슐라크에베르하르드
캄미슈케악셀
외텔미카엘
루에비크알렉산더
실링거에케르하르드
하벤니히트우르술라-프리에데리케
Original Assignee
쉐링 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉐링 악티엔게젤샤프트 filed Critical 쉐링 악티엔게젤샤프트
Publication of KR20020086905A publication Critical patent/KR20020086905A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020027010715A 2000-02-15 2001-02-15 노르에티스테론을 포함하는 남성 피임약 제형 Withdrawn KR20020086905A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493.5 2000-02-15
EP00200493 2000-02-15
US09/503,729 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (en) 2000-02-15 2001-02-15 Male contraceptive formulation comprising norethisterone

Publications (1)

Publication Number Publication Date
KR20020086905A true KR20020086905A (ko) 2002-11-20

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027010715A Withdrawn KR20020086905A (ko) 2000-02-15 2001-02-15 노르에티스테론을 포함하는 남성 피임약 제형

Country Status (26)

Country Link
EP (2) EP1267885B8 (enExample)
JP (1) JP2003522795A (enExample)
KR (1) KR20020086905A (enExample)
CN (1) CN1423560A (enExample)
AT (2) ATE474580T1 (enExample)
AU (1) AU2001230447A1 (enExample)
BG (1) BG107066A (enExample)
BR (1) BR0108411A (enExample)
CA (1) CA2398063A1 (enExample)
CY (1) CY1106639T1 (enExample)
CZ (1) CZ20022691A3 (enExample)
DE (2) DE60142647D1 (enExample)
DK (1) DK1267885T3 (enExample)
EE (1) EE200200454A (enExample)
ES (1) ES2282230T3 (enExample)
HK (1) HK1049442B (enExample)
HU (1) HUP0300128A3 (enExample)
IL (1) IL151219A0 (enExample)
MX (1) MXPA02007675A (enExample)
NO (1) NO20023607L (enExample)
PL (1) PL357185A1 (enExample)
PT (1) PT1267885E (enExample)
RU (1) RU2002124602A (enExample)
SI (1) SI1267885T1 (enExample)
SK (1) SK11602002A3 (enExample)
WO (1) WO2001060376A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
JP4417838B2 (ja) 2002-07-24 2010-02-17 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ７α−置換された１１α−ヒドロキシステロイドの微生物的生成方法
BR0312922A (pt) * 2002-07-25 2005-07-12 Schering Ag Composição contendo um androgênio 11 beta halogênio-esteróide e um gestagênio assim como um contraceptivo masculino à base dessa composição
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
CN112074269A (zh) 2018-03-23 2020-12-11 美卓实验室 用于男性避孕的非激素组合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
HUP0300128A2 (en) 2003-05-28
DE60127103T2 (de) 2007-11-22
DK1267885T3 (da) 2007-07-09
HK1049442B (en) 2007-06-15
RU2002124602A (ru) 2004-03-10
NO20023607D0 (no) 2002-07-30
EE200200454A (et) 2003-12-15
BR0108411A (pt) 2003-03-11
ATE355844T1 (de) 2007-03-15
SK11602002A3 (sk) 2003-03-04
CA2398063A1 (en) 2001-08-23
DE60127103D1 (de) 2007-04-19
HK1049442A1 (en) 2003-05-16
ATE474580T1 (de) 2010-08-15
EP1666044B1 (en) 2010-07-21
PL357185A1 (en) 2004-07-26
CY1106639T1 (el) 2012-01-25
AU2001230447A1 (en) 2001-08-27
HUP0300128A3 (en) 2004-03-29
EP1267885B8 (en) 2007-06-20
WO2001060376A1 (en) 2001-08-23
SI1267885T1 (sl) 2007-08-31
ES2282230T3 (es) 2007-10-16
CN1423560A (zh) 2003-06-11
NO20023607L (no) 2002-10-15
EP1267885B1 (en) 2007-03-07
EP1267885A1 (en) 2003-01-02
JP2003522795A (ja) 2003-07-29
EP1666044A1 (en) 2006-06-07
CZ20022691A3 (cs) 2003-01-15
IL151219A0 (en) 2003-04-10
DE60142647D1 (de) 2010-09-02
PT1267885E (pt) 2007-05-31
MXPA02007675A (es) 2004-02-26
BG107066A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
US20060142257A1 (en) Male contraceptive formulation comprising norethisterone
US7025979B2 (en) Male contraceptive formulation comprising norethisterone
US5891462A (en) Composition for transdermal administration of an estrogen
KR101083696B1 (ko) 경피 흡수 제제
KR101662186B1 (ko) 경피 전달 시스템
EP2861233B1 (en) Transdermal hormone replacement therapies
EP1482925B1 (en) 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
US20030022877A1 (en) Method of increasing testosterone and related steroid concentrations in women
JPH04504848A (ja) エストロゲン感受性疾患の治療のための組合せ療法
EP1390041B1 (en) Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
US20030109507A1 (en) Medicaments based on progestins for dermal use
EP1666044B1 (en) Male contraceptive formulation comprising norethisterone
TW200528073A (en) Transdermal delivery of hormones without the need of penetration enhancers
AU639467B2 (en) Compositions useful as contraceptives in males
HK1090576A (en) Male contraceptive formulation comprising norethisterone
CN101332174A (zh) 二氢睾酮外用制剂及其药物用途
KR100481459B1 (ko) 에스트로겐,프로게스틴또는이의혼합물의경피투여용조성물
US20040259849A1 (en) 17Alpha-hydroxy-14Beta-steroids with hormonal effect
PL214858B1 (pl) Środek leczniczy na bazie noretysteronu lub jego farmaceutycznie dopuszczalnej pochodnej i estradiolu lub jego farmaceutycznie dopuszczalnej pochodnej

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020816

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid